-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
HC Wainwright Reaffirms Buy Rating for ImmunityBio (NASDAQ:IBRX)
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $8.00 price objective on the stock. HC Wainwright’s price target would indicate a potential upside of 221.29% from the stock’s previous close. […]
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $8.00 price objective on the stock. HC Wainwright’s price target would indicate a potential upside of 221.29% from the stock’s previous close. […]
